Literature DB >> 4366916

Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.

A F Back, N J Schmidt.   

Abstract

Envelope, capsid, and soluble antigens of Herpesvirus hominis (HVH) types 1 and 2 were compared to crude antigens (disrupted HVH-infected cells) for potency, type-specificity, and diagnostic value in the indirect hemagglutination (IHA) test. The envelope appeared to be the predominant component reacting in the IHA test, but recurrent HVH infections increased the reactivity of human sera with capsid antigens. The soluble antigens reacted in the IHA test with HVH immune animal sera, but very few convalescent-phase human sera showed reactivity with soluble antigens. Overall, none of the subunit antigens showed greater type-specificity than did crude antigens in IHA tests with immune animal or convalescent-phase human sera. Recurrent infections with type 1 or type 2 viruses tended to broaden heterotypic reactivity of the patients' sera with both crude and subunit antigens, even in patients showing only a single type of antibody by IHA inhibition. Subunit antigens were no more sensitive than crude antigens in demonstrating significant IHA antibody titer rises for serodiagnosis of herpesvirus infections, and they generally had to be used at lower working dilutions than crude antigens.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4366916      PMCID: PMC414963          DOI: 10.1128/iai.10.1.102-106.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  3 in total

1.  Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.

Authors:  P M Feorino; E L Palmer
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

2.  Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition.

Authors:  M T Bernstein; J A Stewart
Journal:  Appl Microbiol       Date:  1971-04

3.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

  3 in total
  5 in total

1.  Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.

Authors:  H W Doerr; G Gross; H Schmitz
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

2.  Comparison of indirect hemagglutination and 51chromium release tests for detection of Herpes Simplex Virus type 1 and 2 antibodies in patients with recurrent Herpes infections.

Authors:  L Kesavalu; P Seth
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Antibody responses in humans to individual proteins of herpes simplex viruses.

Authors:  S C Gilman; J J Docherty; W E Rawls
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.